NANOVIRICIDES, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
NANOVIRICIDES, INC. (NNVC) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $8.13 thousand for the 9-month period ending 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2024-05-15
- NANOVIRICIDES, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2024-03-31 was -$8.13K.
- NANOVIRICIDES, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2023-12-31 was -$8.12K.
- NANOVIRICIDES, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2023-09-30 was $24.37K.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month |
|---|---|---|---|
| 2024-03-31 | -$8.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15 | -$16.25K derived: sum of 2 quarters · filed 2024-05-15 | $8.13K 10-Q · filed 2024-05-15 |
| 2023-12-31 | -$8.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-14 | $16.25K 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $24.37K 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |